Current and Future Strategies for the Prevention and Treatment of Cytomegalovirus Infections in Transplantation
Clinical Infectious Diseases · 06.10.2025 · 81 (3) · 581-592
DOI: 10.1093/cid/ciae535 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Infectious Diseases, online erschienen am 04.11.2024. Verfasst von Madeleine R Heldman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Organ Transplantation. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
Abstract (Originalsprache)
Successful prevention and treatment of cytomegalovirus (CMV) infection remains a central focus of clinical care in solid organ transplantation (SOT) and allogeneic hematopoietic cell transplantation (HCT). Over the past 5 years, pivotal clinical trials have created new paradigms in CMV prevention, including diverging approaches in HCT and SOT. We review recent advances in CMV risk assessment and progress in antiviral and immune-based strategies for CMV prevention and treatment. We highlight approaches to optimize CMV-specific immunity through vaccination, monoclonal antibodies, and virus-specific T cells. Observational studies and interventional trials of commercially available CMV cell-mediated immunity assays for refining preventive and treatment strategies are summarized. Finally, we discuss the importance of enhancing CMV-specific immunity to mitigate the negative impacts of CMV in different transplant settings. CMV infections in recipients of chimeric antigen receptor-T (CAR-T) cell therapies and other immunocompromised populations are growing areas of importance that are beyond the scope of this review.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
- Division of Allergy and Infectious Diseases Division, Department of Medicine, University of Washington, Seattle, Washington, USA.
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
- Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
- Division of Infectious Diseases, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
ORCID-Profile: Madeleine R Heldman, Michael J Boeckh, Ajit P Limaye
Förderung
- National Institute of Allergy and Infectious Diseases at the National Institutes of Health
Zitieren
APA
Heldman, M. R., Boeckh, M. J., & Limaye, A. P. (2025). Current and Future Strategies for the Prevention and Treatment of Cytomegalovirus Infections in Transplantation. Clinical Infectious Diseases, 81(3), 581-592. https://doi.org/10.1093/cid/ciae535
Vancouver
Heldman MR, Boeckh MJ, Limaye AP. Current and Future Strategies for the Prevention and Treatment of Cytomegalovirus Infections in Transplantation. Clinical Infectious Diseases. 2025;81(3):581-592. doi:10.1093/cid/ciae535
BibTeX
@article{Heldman2025,
author = {Heldman, Madeleine R and Boeckh, Michael J and Limaye, Ajit P},
title = {Current and Future Strategies for the Prevention and Treatment of Cytomegalovirus Infections in Transplantation},
journal = {Clinical Infectious Diseases},
year = {2025},
volume = {81},
number = {3},
pages = {581--592},
doi = {10.1093/cid/ciae535}
}
EUVIMED